Jason Day
- Firmwide Co-Chair, Corporate Practice
Jason serves as a trusted advisor to leading publicly traded companies on their most important corporate governance, capital markets and transactional matters.
Jason Day serves as a trusted advisor to public companies on their most sensitive and high-value securities, corporate governance, and capital markets matters. Jason also serves as co-chair of the firm’s global Corporate practice. He regularly counsels public company boards of directors and management on U.S. Securities and Exchange Commission disclosure obligations; capital markets deals; environmental, social, and governance disclosures; fiduciary duties; internal investigations; proxy advisory firm standards; and stockholder activism matters. His clients range from businesses preparing for an initial public offering (IPO) to Fortune 500 corporations across a variety of industries, and he has particular experience in the life sciences, consumer products, energy, technology, and food and beverage sectors.
Over his 20-plus-year career, Jason has represented issuers and underwriters in raising tens of billions of dollars in capital markets offerings, including underwritten equity and debt offerings, IPOs, Rule 144A offerings, and convertible note offerings, among others. He also regularly counsels companies and their boards of directors on the acquisition and sales of public companies and other transformative mergers and acquisition transactions.
Jason is a co-author of The Public Company Handbook: A Corporate Governance and Disclosure Guide for Directors and Executives and is a frequent speaker on a variety of public company topics.
Education & Credentials
Education
- The George Washington University Law School, J.D.
- Syracuse University, B.A.
Bar and Court Admissions
-
Colorado
Professional Recognition
Ranked by Chambers USA as "America's Leading Lawyer" for Corporate: Mergers & Acquisitions, 2016-2024
Listed in The Best Lawyers in America: Corporate Governance Law; Securities / Capital Markets Law; Securities Regulation, 2014-2024
Named “Corporate Governance Law Lawyer of the Year” by Best Lawyers in America, 2021
Named "Lawyer of the Year," for Securities / Capital Markets Law and Securities Regulation by Best Lawyers in America, 2020
Listed in 5280 as one of Denver's Top Lawyers, 2016-2020
Named Lexology and International Law Office (ILO), Client Choice Award: Capital Markets, 2014-2015
Named "Colorado Lawyer of the Year" by Law Week Colorado, 2013
Named a "Colorado Super Lawyer," by Super Lawyers, 2014-2018
Named a "Colorado Rising Star," by Super Lawyers, 2012-2013
Listed in the Legal 500 under capital markets-equity offerings, 2011
Impact
Professional Leadership
- Colorado Bar Association Securities Law Section, Co-Chair, 2009-2011
Community Involvement
- Syracuse University College of Arts and Sciences, Former Member, Board of Visitors
- Easter Seals of Colorado, Former Member, Board of Directors
Insights
News
Professional Experience
Corporate Finance
Amcor PLC
Represented Amcor PLC in an issuance of $800 million senior notes offering.
Gevo, Inc.
Represented Gevo, Inc. in its $350-million public offering of common stock.
Crocs, Inc.
Represented Crocs, Inc. in an issuance of $350 million senior notes.
Pacira BioSciences, Inc.
Represented Pacira BioSciences, Inc. in a $402 million convertible note offering.
Molson Coors Brewing Company
Representation of Molson Coors in connection with its $2.5 billion class B Common stock offering and $1.5 billion commercial paper facility.
M/A-COM Technology Solutions Inc. IPO & Follow-on Offering
Representation of M/A-Com Technology Solutions Inc. in connection with its initial public offering and follow-on common stock offering.
T-Mobile USA, Inc.
Represented T-Mobile USA, Inc. in a $5.6 billion secondary offering of senior unsecured notes by majority stockholder, Deutsche Telekom AG.
T-Mobile USA, Inc.
Represented T-Mobile USA, Inc. in an aggregate of $2.8 billion of public offerings of common and preferred stock.
Crocs, Inc.
Representation of Crocs, Inc. in connection with its sale of $200 million in preferred stock to affiliates of Blackstone and subsequent secondary public offerings by Blackstone.
Pacira Pharmaceuticals, Inc.
Represented Pacira in a $118 million follow-on public offering and $345 million convertible note offering.
Initial Public Offerings
Representation of insurance, retail, technology and medical device companies in connection with their initial public offerings.
Underwritten Public Offerings
Representation of various issuers and underwriters in connection with underwritten public offerings.
Mergers & Acquisitions
Crocs, Inc.
Represented Crocs in $2.5 Billion acquisition of HEYDUDE.
Pacira Pharmaceuticals, Inc.
Represented Pacira BioSciences in its acquisition of Flexion Therapeutics (NASDAQ: FLXN).
Maverick Therapeutics, Inc.
Represented Maverick Therapeutics in its acquisition by Takeda Pharmaceutical Company.
Pacira Pharmaceuticals, Inc.
Represented Pacira BioSciences in its acquisition of MyoScience.
Peak Resorts, Inc.
Represented Missouri-based Peak Resorts, Inc. (NASDAQ: SKIS), a publicly traded owner and operator of 17 ski resorts in the Northeast and Midwest, in its acquisition by Vail Resorts, Inc. for approximately $264 million in cash and assumption of additional debt.
Thompson Creek Metals Company Inc.
Represented Thompson Creek Metals Company Inc. (TSX:TCM) (OTCQX:TCPTF) in its $1.1billion acquisition by Centerra Gold Inc. (TSX:CG).
M/A-COM Technology Solutions Holdings, Inc.
Represented M/A-COM Technology Solutions Holdings, Inc. (NASDAQ:MTSI) in connection with its acquisition of Mindspeed Technologies, Inc. (NASDAQ:MSPD), BinOptics and several others.
Acquisitions of Various Public and Private Companies
Representation of private equity funds and strategic buyers in connection with their acquisitions of various public and private companies.
Sale of Public Companies
Representation of various public companies in connection with their sales to strategic and financial buyers.